| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
14,413 |
9,346 |
$1.49M |
| H2020 |
Therapeutic behavioral services, per diem |
137 |
75 |
$11K |
| 99051 |
|
35 |
24 |
$247.18 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,120 |
5,336 |
$116.28 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
651 |
472 |
$76.96 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,384 |
4,129 |
$50.12 |
| 36415 |
Collection of venous blood by venipuncture |
3,405 |
1,982 |
$1.72 |
| 82962 |
|
3,052 |
2,128 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,068 |
2,448 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,270 |
1,016 |
$0.00 |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
1,841 |
1,336 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
1,207 |
974 |
$0.00 |
| 90688 |
|
164 |
128 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
355 |
292 |
$0.00 |
| 86769 |
|
379 |
276 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
252 |
185 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,317 |
924 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
20 |
12 |
$0.00 |
| 90674 |
|
46 |
35 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
13 |
12 |
$0.00 |
| 81003 |
|
1,657 |
1,008 |
$0.00 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
48 |
39 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
675 |
508 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
300 |
212 |
$0.00 |
| 82947 |
|
217 |
177 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
554 |
429 |
$0.00 |
| 82948 |
|
241 |
180 |
$0.00 |
| 90658 |
|
23 |
18 |
$0.00 |